250 related articles for article (PubMed ID: 1374733)
1. Pancreatic tumor antigens: diagnostic markers and targets for immunotherapy.
Finn OJ
Important Adv Oncol; 1992; ():61-77. PubMed ID: 1374733
[No Abstract] [Full Text] [Related]
2. Potential clinical utility of monoclonal antibodies in the management of human carcinomas.
Schlom J; Weeks MO
Important Adv Oncol; 1985; ():170-92. PubMed ID: 3916739
[No Abstract] [Full Text] [Related]
3. Development and evaluation of monoclonal antibody-based immunoassays: breast carcinoma-associated mucins as tumor markers.
Brown JP; Linsley PS; Horn D
Immunol Ser; 1990; 53():69-82. PubMed ID: 1713071
[No Abstract] [Full Text] [Related]
4. Pancarcinoma T and Tn epitopes: autoimmunogens and diagnostic markers that reveal incipient carcinomas and help establish prognosis.
Springer GF; Desai PR; Wise W; Carlstedt SC; Tegtmeyer H; Stein R; Scanlon EF
Immunol Ser; 1990; 53():587-612. PubMed ID: 1713069
[No Abstract] [Full Text] [Related]
5. Targeted cellular immunotherapy with bifunctional antibodies.
Nelson H
Cancer Cells; 1991 May; 3(5):163-72. PubMed ID: 1832553
[TBL] [Abstract][Full Text] [Related]
6. DU-PAN-2, mucin type differentiation antigen of normal and malignant pancreatic ductal cells.
Metzgar RS; Lan MS; Kim YW; Koriwchak MJ; Mullins TD; Hollingsworth MA
Prog Clin Biol Res; 1989; 288():53-61. PubMed ID: 2717641
[No Abstract] [Full Text] [Related]
7. Peptide mimics of a tumor antigen induce functional cytotoxic T cells.
Apostolopoulos V; Lofthouse SA; Popovski V; Chelvanayagam G; Sandrin MS; McKenzie IF
Nat Biotechnol; 1998 Mar; 16(3):276-80. PubMed ID: 9528009
[TBL] [Abstract][Full Text] [Related]
8. Genes coding for tumor rejection antigens: perspectives for specific immunotherapy.
Boon T; Coulie P; Marchand M; Weynants P; Wölfel T; Brichard V
Important Adv Oncol; 1994; ():53-69. PubMed ID: 8206495
[No Abstract] [Full Text] [Related]
9. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells.
Jerome KR; Barnd DL; Bendt KM; Boyer CM; Taylor-Papadimitriou J; McKenzie IF; Bast RC; Finn OJ
Cancer Res; 1991 Jun; 51(11):2908-16. PubMed ID: 1709586
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers.
Imai K; Hirata S; Irie A; Senju S; Ikuta Y; Yokomine K; Harao M; Inoue M; Tsunoda T; Nakatsuru S; Nakagawa H; Nakamura Y; Baba H; Nishimura Y
Clin Cancer Res; 2008 Oct; 14(20):6487-95. PubMed ID: 18927288
[TBL] [Abstract][Full Text] [Related]
12. Polypeptide core of a human pancreatic tumor mucin antigen.
Lan MS; Hollingsworth MA; Metzgar RS
Cancer Res; 1990 May; 50(10):2997-3001. PubMed ID: 2334903
[TBL] [Abstract][Full Text] [Related]
13. [Monoclonal antibodies and cancer].
López González JS; Selman Lama M
Salud Publica Mex; 1985; 27(3):213-34. PubMed ID: 2996157
[No Abstract] [Full Text] [Related]
14. Mucin glycoproteins as tumor markers.
Feller WF; Henslee JG; Kinders RJ; Manderino GL; Tomita JT; Rittenhouse HG
Immunol Ser; 1990; 53():631-72. PubMed ID: 2100576
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies to detect breast cancer cells in bone marrow.
Diel IJ; Kaufmann M; Costa SD; Bastert G
Important Adv Oncol; 1994; ():143-64. PubMed ID: 8206487
[No Abstract] [Full Text] [Related]
16. Tumor-associated glycolipid antigens defined by monoclonal antibodies.
Hakomori S
Bull Cancer; 1983; 70(2):118-26. PubMed ID: 6191806
[TBL] [Abstract][Full Text] [Related]
17. Murine immune response to cells transfected with human MUC1: immunization with cellular and synthetic antigens.
Apostolopoulos V; Xing PX; McKenzie IF
Cancer Res; 1994 Oct; 54(19):5186-93. PubMed ID: 7923138
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA.
Jerome KR; Domenech N; Finn OJ
J Immunol; 1993 Aug; 151(3):1654-62. PubMed ID: 8393050
[TBL] [Abstract][Full Text] [Related]
19. CTLA-4 blockade: autoimmunity as treatment.
Kapadia D; Fong L
J Clin Oncol; 2005 Dec; 23(35):8926-8. PubMed ID: 16204008
[No Abstract] [Full Text] [Related]
20. Biological, molecular, and clinical markers for the diagnosis and typing of lung cancer.
Gazdar AF; Mulshine JL; Kramer BS
Immunol Ser; 1990; 53():453-68. PubMed ID: 1966068
[No Abstract] [Full Text] [Related]
[Next] [New Search]
